Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orasure (OSUR)
:OSUR
Holding OSUR?
Track your performance easily
Earnings Data
Report Date
Feb 19, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.06Last Year’s EPS
0.27Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2018
|% Change Since: -17.05%
|Next Earnings Date:Aug 08, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments, such as strong growth in international diagnostics and strategic advancements like the proteomics launch, alongside challenges like the declining risk assessment business and market turmoil in consumer genomics. While strategic initiatives and innovation efforts signal potential for future growth, the financials reflect ongoing adjustments and market challenges.Company Guidance
During the OraSure Technologies Q3 2024 earnings call, the company provided guidance indicating a projected total revenue for Q4 in the range of $36 million to $38 million, with core revenue expected between $35 million and $37 million. This guidance reflects a return to year-over-year growth in core revenue, anticipated to be 5%, excluding their exiting risk assessment business. The company also discussed gross margins, noting they expect Q4 gross margins to remain consistent with Q3 at approximately 42.8%, impacted by international business mix and costs associated with winding down the risk assessment segment. Additionally, the guidance included $1 million from COVID-19 product revenues for Q4, expected to be the run rate through Q1 2025. The company highlighted strategic initiatives such as the planned launch into the blood proteomics market in the second half of 2025 and the continued focus on operational efficiencies and innovation to drive long-term growth and improve margins towards the 50% range.Strong International Diagnostics Growth
Diagnostics products generated $22 million of revenue in Q3, increasing 13% year-over-year, driven by strong international HIV business.
Positive Operating Cash Flow
Generated $12.7 million of operating cash flow during Q3, including positive cash flow from operations for the core business.
WHO Prequalification for OraQuick HCV Self-test
Received initial international orders for OraQuick HCV Self-test after WHO prequalification, marking it as the first Hepatitis C self-test to earn this designation.
Launch in Blood Proteomics Market
Planned launch of a new solution targeting the blood proteomics market in the second half of 2025, aiming to address chronic illnesses and research applications.
Strategic Focus and Streamlining
Initiatives to exit the risk assessment testing business and complete restructuring to focus on diagnostics and sample management solutions.
---
OSUR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
OSUR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $4.40 | $4.24 | -3.64% |
| Aug 06, 2024 | $4.32 | $4.34 | +0.46% |
| May 08, 2024 | $5.31 | $5.04 | -5.08% |
| Feb 27, 2024 | $7.03 | $7.73 | +9.96% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Orasure (OSUR) report earnings?
Orasure (OSUR) is schdueled to report earning on Feb 19, 2025, TBA Not Confirmed.
What is Orasure (OSUR) earnings time?
Orasure (OSUR) earnings time is at Feb 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OSUR EPS forecast?
OSUR EPS forecast for the fiscal quarter 2024 (Q4) is -0.06.
---